Well, at least GSK and Biota should have informed
the public that IV Relenza is under emergency IND:
Page 244
"The two that are currently available under an
emergency IND are IV zanamivir, and IV
Peramivir."
Im not criticizing BTA-management many times, BUT:
Emergency IND is a proven FACT and its absolutely
unacceptable that neither BTA nor GSK have made
any report about that !